IL22 and Hyperglycemia: SCFAs increase the AhR expression in CD4 T cells by activating STAT3 and mTOR signaling pathways after binding to the GPR41 and then promoted the production of IL-22; amino acids also promote IL-22 production after being metabolized by microorganisms into AhR ligands, and the increase of IL-22 improves hyperglycemia.